CHA(CHA)
CHA
Q4 2026 EPS Estimate
$0.32
Nov 27, 2026
Revenue Estimate
$560M
FY2026E EPS$8.90
FY2027E EPS$9.83
Analyst Sentiment
Wall St. Consensus
Hold14 analysts·Moderate coverage
61
Score
7 Buy (50%)6 Hold (43%)1 Sell (7%)
Rating Breakdown
Strong Buy
00%
Buy
750%
Hold
643%
Sell
17%
Strong Sell
00%
Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.
Price Target Expectations
Bear
$10.00
-7.4%
Consensus
$13.60
+25.9%
Bull
$15.50
+43.5%
12-Month Target Range14 analysts
$10.00$13.60$15.50
Current $10.80Consensus
Current Price
$10.80
Upside to Consensus
$2.80
Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.
Earnings & Revenue Estimates
Forward Growth Estimates (YoY)
FY2027
Rev+11.09%
EPS+10.48%
FY2028
Rev+7.50%
EPS+7.78%
Raw consensus estimates (low / average / high) from covering analysts.
Annual
| Metric | FY2026E | FY2027E | FY2028E |
|---|---|---|---|
| Revenue Avg | $14.22B | $15.79B | $16.98B |
| Low | $14.15B | $14.89B | $16.01B |
| High | $14.29B | $15.86B | $17.62B |
| EBITDA Avg | $2.03B | $2.26B | $2.45B |
| Low | $1.90B | $2.11B | $2.28B |
| High | $2.13B | $2.36B | $2.56B |
| EBIT Avg | $1.86B | $2.05B | $2.21B |
| Low | $1.72B | $1.90B | $2.05B |
| High | $1.95B | $2.15B | $2.32B |
| Net Income Avg | $1.47B | $1.62B | $1.75B |
| Low | $1.36B | $1.50B | $1.62B |
| High | $1.54B | $1.70B | $1.83B |
| EPS Avg | $8.90 | $9.83 | $10.60 |
| Low | $8.24 | $9.10 | $9.81 |
| High | $9.34 | $10.32 | $11.12 |
| Analysts (Rev / EPS) | 6 / 4 | 6 / 4 | 2 / 2 |
Quarterly
| Metric | Q3 2026 | Q4 2026 | Q1 2027 | Q2 2027 | Q3 2027 | Q4 2027 | Q1 2028 | Q2 2028 |
|---|---|---|---|---|---|---|---|---|
| Revenue Avg | $3.80B | $3.52B | $4.19B | $4.04B | $3.94B | $3.79B | $4.53B | $4.36B |
| Low | $3.79B | $3.50B | $4.06B | $3.91B | $3.81B | $3.67B | $4.39B | $4.23B |
| High | $3.81B | $3.53B | $4.28B | $4.13B | $4.02B | $3.87B | $4.63B | $4.46B |
| EBITDA Avg | $581M | $387M | $611M | $599M | $555M | $382M | $540M | $471M |
| Low | $558M | $373M | $587M | $575M | $534M | $367M | $519M | $454M |
| High | $597M | $397M | $627M | $614M | $570M | $391M | $554M | $483M |
| EBIT Avg | $555M | $358M | $579M | $564M | $518M | $343M | $498M | $427M |
| Low | $532M | $344M | $555M | $541M | $497M | $328M | $478M | $410M |
| High | $570M | $368M | $596M | $580M | $533M | $352M | $512M | $439M |
| Net Income Avg | $437M | $282M | $457M | $445M | $408M | $270M | $393M | $337M |
| Low | $419M | $271M | $438M | $426M | $391M | $259M | $376M | $323M |
| High | $449M | $290M | $469M | $457M | $420M | $277M | $404M | $346M |
| EPS Avg | $2.27 | $1.46 | $2.37 | $2.30 | $2.12 | $1.40 | $2.03 | $1.74 |
| Low | $2.17 | $1.40 | $2.27 | $2.21 | $2.03 | $1.34 | $1.95 | $1.67 |
| High | $2.33 | $1.50 | $2.43 | $2.37 | $2.17 | $1.44 | $2.09 | $1.79 |
| Analysts (Rev / EPS) | 2 / 1 | 2 / 1 | 1 / 1 | 1 / 1 | 1 / 1 | 1 / 1 | 1 / 1 | 1 / 1 |